The long term goal of this research is to determine what role polyphosphoinositides phosphorylated at the D-3 position of the inositol ring play in growth factor stimulation of cells. This laboratory recently discovered three new polyphosphoinositides not in the pathway for generation of inositol-1,4,5-trisphosphate. The enzyme which produces these lipids was discovered because of a tight association with several protein-tyrosine kinases, including the platelet derived growth factor (PDGF) receptor. This association occurs within 15 seconds of PDGF addition to quiescent fibroblasts. In vitro this activity phosphorylates phosphatidylinositol (PI) to produce phosphatidylinositol-3-phosphate (PI- 3-P). When phosphatidylinositol-4-phosphate (PI-4-P) is used as a substrate, a lipid whose structure appears to be phosphatidylinositol-3,4- bisphosphate (PI-3-4-P2) is produced and when phosphatidylinositol-4,5- bisphosphate (PI-4,5-P2) is added, phosphatidylinositol-trisphosphate (PIP3) is produced. We have evidence that a single enzyme phosphorylates all three substrates at the D-3 position. These results along with observations that the same PI kinase activities associate with the middle t transforming gene product of polyoma virus but fail to associate with transformation defective mutants suggest that this novel pathway mediates an important signal in growth and transformation. PI-3-P has now been found in a variety of proliferating cells from yeast to mammalian fibroblasts, and the PI-3,4-P2 and PIP3 have been shown to be produced in cells stimulated with PDGF or transformed with polyoma virus. The focus of this research will be to elucidate the metabolic pathway and determine whether this is a novel signal transduction system parallel to the inositol-1,4,5-trisphosphate system.
The specific aims of this proposal are to 1) complete the structural analysis of these lipids, 2) investigate changes in vivo levels of these lipids in response to specific growth factors and oncogenes, 3) determine the pathways for synthesis and degradation of these lipids, and 4) determine the effects of these lipids on cell morphology and physiology. Our preliminary studies with mutated oncogenes and growth factor receptors strongly argue that synthesis of the D-3 phosphorylated polyphosphoinositides is a critical event in stimulation of cell growth. Understanding this pathway should shed light on the biochemical basis of cell growth and oncogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM041890-05
Application #
3300351
Study Section
Physical Biochemistry Study Section (PB)
Project Start
1992-11-01
Project End
1995-03-31
Budget Start
1993-04-01
Budget End
1994-03-31
Support Year
5
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Lundquist, Mark R; Goncalves, Marcus D; Loughran, Ryan M et al. (2018) Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy. Mol Cell 70:531-544.e9
Hopkins, Benjamin D; Pauli, Chantal; Du, Xing et al. (2018) Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature 560:499-503
Croessmann, Sarah; Sheehan, Jonathan H; Lee, Kyung-Min et al. (2018) PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K? Inhibitors. Clin Cancer Res 24:1426-1435
Liu, Hui; Murphy, Charles J; Karreth, Florian A et al. (2018) Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer. Cancer Discov 8:354-369
Patnaik, Akash; Swanson, Kenneth D; Csizmadia, Eva et al. (2017) Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity. Cancer Discov 7:750-765
Mayer, Ingrid A; Abramson, Vandana G; Formisano, Luigi et al. (2017) A Phase Ib Study of Alpelisib (BYL719), a PI3K?-Specific Inhibitor, with Letrozole in ER+/HER2- Metastatic Breast Cancer. Clin Cancer Res 23:26-34
Lee, Gina; Zheng, Yuxiang; Cho, Sungyun et al. (2017) Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 Signaling. Cell 171:1545-1558.e18
Fruman, David A; Chiu, Honyin; Hopkins, Benjamin D et al. (2017) The PI3K Pathway in Human Disease. Cell 170:605-635
Pauli, Chantal; Hopkins, Benjamin D; Prandi, Davide et al. (2017) Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine. Cancer Discov 7:462-477
Waldhart, Althea N; Dykstra, Holly; Peck, Anderson S et al. (2017) Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response to Insulin. Cell Rep 19:2005-2013

Showing the most recent 10 out of 164 publications